Tysabri Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

tysabri

biogen nz biopharma ltd - natalizumab 20 mg/ml;   - solution for infusion - 300 mg/15ml - active: natalizumab 20 mg/ml   excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - indicated as monotherapy for the treatment of patients with relapsing remitting multiple sclerosis (ms) to delay the progression of physical disability and to reduce the frequency of relapse. the safety and efficacy of tysabri beyond two years are unknown

HERZUMA KIT Καναδάς - Αγγλικά - Health Canada

herzuma kit

celltrion healthcare co ltd - trastuzumab - kit - 440mg - trastuzumab 440mg - antineoplastic agents

HERZUMA POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

herzuma powder for solution

celltrion healthcare co ltd - trastuzumab - powder for solution - 150mg - trastuzumab 150mg - antineoplastic agents

ONTRUZANT POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

ontruzant powder for solution

samsung bioepis co., ltd - trastuzumab - powder for solution - 150mg - trastuzumab 150mg

ONTRUZANT POWDER FOR SOLUTION Καναδάς - Αγγλικά - Health Canada

ontruzant powder for solution

samsung bioepis co., ltd - trastuzumab - powder for solution - 440mg - trastuzumab 440mg

LUMYKRAS Ισραήλ - Αγγλικά - Ministry of Health

lumykras

amgen europe b.v. - sotorasib - film coated tablets - sotorasib 120 mg - sotorasib - lumykras is indicated for the treatment of adult patients with kras g12c-mutated locally advanced or metastatic non-small cell lung cancer (nsclc), as determined by an approved test, who have received at least one prior systemic therapy.

Mitoxantron Sandoz, 2 mg/mL, concentrate for solution for infusion Μάλτα - Αγγλικά - Medicines Authority

mitoxantron sandoz, 2 mg/ml, concentrate for solution for infusion

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Onkotrone 2mg, solution for injection Μάλτα - Αγγλικά - Medicines Authority

onkotrone 2mg, solution for injection

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - solution for injection - mitoxantrone 2 mg - antineoplastic agents